Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1069377011 | 10693770 | 11 | F | 20141211 | 20160317 | 20150106 | 20160331 | EXP | US-CELGENE-USA-2014124358 | CELGENE | 41.57 | YR | F | Y | 0.00000 | 20160331 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1069377011 | 10693770 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | 21880 | 25 | MG | CAPSULES | QD | ||||||
| 1069377011 | 10693770 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | 21880 | 10 | MG | CAPSULES |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1069377011 | 10693770 | 1 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1069377011 | 10693770 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1069377011 | 10693770 | Human chorionic gonadotropin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1069377011 | 10693770 | 1 | 20130710 | 20130911 | 0 | |
| 1069377011 | 10693770 | 2 | 20140311 | 0 |